(repost): Combination therapy: intermittent sorafenib with bevacizumab yields activity and decreased toxicity : BMJ Ovarian Cancer and Us OVARIAN CANCER and US Ovarian Cancer and Us

Blog Archives: Nov 2004 - present

#ovariancancers



Special items: Ovarian Cancer and Us blog best viewed in Firefox

Search This Blog

Sunday, January 10, 2010

(repost): Combination therapy: intermittent sorafenib with bevacizumab yields activity and decreased toxicity : BMJ



abstract only - BMJ does not have open access (pay per view/subscription req'd)

0 comments :

Post a Comment

Your comments?

Note: Only a member of this blog may post a comment.